Daegu Catholic University Medical Center

Futó vizsgálatok

• Még nem toboroz

  A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity

  NCT07861100· 3. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  Safety and Efficacy of NDTx-03 in Children and Adolescents With ASD or SCD

  NCT07770867· Neudive Inc.· Forrás

• Toboroz

  A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

  NCT07623161· 3. fázis· Takeda· Forrás

• Toboroz

  Optimal Timing of Staged Complete Revascularization in STEMI With Multivessel Disease (OPTION-STEMI2)

  NCT07741721· Chonnam National University Hospital· Forrás

• Még nem toboroz

  Functional And STructural Assesment of the Heart by Artificial Intelligence-enabled Electrocardiogram for the Management of Atrial Fibrillation

  NCT07486739· Seoul National University Hospital· Forrás

• Toboroz

  A Study of E6742 in Participants With Systemic Lupus Erythematosus

  NCT07515014· 2. fázis· Eisai Co., Ltd.· Forrás

• Toboroz

  A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

  NCT07241390· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease

  NCT07223593· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Pilot Study on Efficacy of Digital Therapeutic NDTx-02 for Executive Function in Children and Adolescents With ADHD or ASD

  NCT07242625· Neudive Inc.· Forrás

• Toboroz

  Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

  NCT07007312· 3. fázis· Kura Oncology, Inc.· Forrás

• Fut, nem toboroz

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  NCT07037433· 3. fázis· Amgen· Forrás

• Toboroz

  ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement

  NCT05672836· 4. fázis· Duk-Woo Park, MD· Forrás

• Fut, nem toboroz

  Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML

  NCT06578247· 3. fázis· Daiichi Sankyo· Forrás

• Toboroz

  Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke

  NCT06649240· Seoul National University Hospital· Forrás

• Toboroz

  Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine

  NCT06603558· AbbVie· Forrás

• Toboroz

  Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease

  NCT05831085· Duk-Woo Park, MD· Forrás

• Toboroz

  Fractional Flow Reserve Versus Angiography for Treatment-Decision and Evaluation of Significant Left MAIN Coronary Artery Disease

  NCT05829889· Seung-Jung Park· Forrás

• Toboroz

  OCT Versus Angiography for Culprit Lesion Revascularization in Acute Myocardial Infarction PatiEnts

  NCT06227754· Chonnam National University Hospital· Forrás

• Fut, nem toboroz

  A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus

  NCT05648500· 3. fázis· Viatris Innovation GmbH· Forrás

• Toboroz

  OPTIMIZE-APT: Tailored Versus Conventional Antiplatelet Therapy After Intravascular Imaging-guided Drug-eluting Stent Implantation

  NCT05418556· 4. fázis· Asan Medical Center· Forrás

• Fut, nem toboroz

  Safety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL Patients

  NCT05222555· 1/2. fázis· Incyte Corporation· Forrás

• Fut, nem toboroz

  Korean Registry of Non-Small Cell Lung Cancer Patients with EGFR Mutation

  NCT06247280· Yuhan Corporation· Forrás

• Fut, nem toboroz

  A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.

  NCT04680052· 3. fázis· Incyte Corporation· Forrás

• Fut, nem toboroz

  Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)

  NCT04603495· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  Evaluation of Effectiveness and Safety of Ultimaster™ Tansei™ Stent and/or Ultimaster Nagomi™ Stent in Routine Clinical Practice

  NCT04443530· Duk-Woo Park, MD· Forrás

• Fut, nem toboroz

  Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance

  NCT04285086· 3. fázis· PharmaEssentia· Forrás

• Toboroz

  Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice

  NCT03427996· Seung-Jung Park· Forrás

• Fut, nem toboroz

  IRIS-Synergy Cohort in the IRIS-DES Registry

  NCT02720419· Jung-min Ahn· Forrás

• Fut, nem toboroz

  IRIS-Onyx Cohort in the IRIS-DES Registry

  NCT02593994· Seung-Jung Park· Forrás

• Toboroz

  Observational Study for Left Main Disease Treatment

  NCT01341327· Seung-Jung Park· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Koszorúér-betegség8 toboroz
• Autizmus spektrumzavar2 toboroz
• Stroke (szélütés)2 toboroz
• Akut mieloid leukémia (AML)1 toboroz
• Aortic stenosis1 toboroz
• Elhízás1 toboroz
• Krónikus vesebetegség1 toboroz
• Lupus (SLE)1 toboroz
• Mieloproliferatív neopláziák1 toboroz
• Migrén1 toboroz
• Peripheral artery disease1 toboroz
• Pitvarfibrilláció1 toboroz
• Szívelégtelenség1 toboroz

Lezárt vizsgálatok

• Lezárult

  To Evaluate the Efficacy and Safety of 'NDTx-01' in Patients With ASD or SCD

  NCT06446193· Neudive Inc.· Forrás

• Lezárult

  Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)

  NCT06122961· Novo Nordisk A/S· Forrás

• Lezárult

  Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With Albuminuria

  NCT05718375· 2. fázis· Curacle Co., Ltd.· Forrás

• Lezárult

  Efficacy and Safety of Ezetimibe/Rosuvastatin and Amlodipine Patients With High Blood Pressure and High Cholesterol

  NCT07564726· 3. fázis· Celltrion Pharm, Inc.· Forrás

• Leállították

  Trial of Atezolizumab and Bevacizumab With CHS-388 or Placebo in Patients With Hepatocellular Carcinoma

  NCT05359861· 2. fázis· Coherus Oncology, Inc.· Forrás

• Lezárult

  ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation

  NCT05021835· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2)

  NCT04846881· 3. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis

  NCT04541810· AbbVie· Forrás

• Leállították

  Clinical Implication of Atrial Fibrillation Detection Using Wearable Device in Patients With Cryptogenic Stroke

  NCT04624646· Ewha Womans University Mokdong Hospital· Forrás

• Lezárult

  Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis

  NCT04433442· AbbVie· Forrás

• Lezárult

  Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia

  NCT06293261· Yuhan Corporation· Forrás

• Lezárult

  Resolution of Thrombi in Left Atrial Appendage With Edoxaban

  NCT03840291· 4. fázis· Keimyung University Dongsan Medical Center· Forrás

• Lezárult

  Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients

  NCT03776123· Ipsen· Forrás

• Lezárult

  Post Marketing Surveillance Study for ADYNOVATE in South Korea

  NCT03824522· Takeda· Forrás

• Lezárult

  TAILored Versus COnventional AntithRombotic StratEgy IntenDed for Complex HIgh-Risk PCI

  NCT03465644· 4. fázis· Duk-Woo Park, MD· Forrás

• Lezárult

  Post Marketing Surveillance on Safety Evaluation of POMALYST® (Pomalidomide) Treatment of Multiple Myeloma in Korea

  NCT03288974· Celgene· Forrás

• Lezárult

  Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis

  NCT03025308· 3. fázis· Alfasigma S.p.A.· Forrás

• Leállították

  A Study of H3B-8800 (RVT-2001) in Participants With Lower Risk Myelodysplastic Syndromes

  NCT02841540· 1. fázis· Hemavant Sciences GmbH· Forrás

• Lezárult

  IRIS Ultimaster Cohort in the IRIS-DES Registry

  NCT02719106· Duk-Woo Park, MD· Forrás

• Leállították

  Evaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Routine Clinical Practice

  NCT02622100· Duk-Woo Park, MD· Forrás

• Lezárult

  XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice

  NCT02042300· Seung-Jung Park· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Hemofília6 munka · 1 vizsgálat
• Magas vérnyomás6 munka · 2 vizsgálat